Crossmark

The 5W1H in antiplatelet monotherapy after percutaneous coronary intervention: what, who, where, when, why, and how?

Crossref DOI link: https://doi.org/10.1016/j.rec.2021.08.008

Published Print: 2022-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Baber, Usman
License Information

Text and Data Mining valid from 2022-02-01
More Information

This article is maintained by: Elsevier

Article Title: The 5W1H in antiplatelet monotherapy after percutaneous coronary intervention: what, who, where, when, why, and how?

Journal Title: Revista Española de Cardiología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rec.2021.08.008

Content Type: article

Copyright: © 2021 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Cardiología.